drugset / Trial / NCT00761098

Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis (SBP)

NCT00761098

Phase 4 Unknown 80 enrolled Weill Medical College of Cornell University
RandomizedParallel-groupOpen-labelTreatment

Summary

Spontaneous bacterial peritonitis (SBP) is a common and frequently fatal complication of end-stage liver disease with a mortality of up to 10%, primarily due to the development of kidney failure. Current standard practice is to treat this infection with broad spectrum antibiotics and salt-poor albumin administration on day one and three of treatment. In this study the investigators test the hypothesis that the administration of a second dose of albumin at 48 hours only to patients with renal insufficiency, is as effective at preventing kidney failure as administering the second dose to all patients at 72 hours.

Timeline

Start
2005-05
Primary completion
2010-05
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Albumin Protein / enzyme biologic 1 g/kg